IndiaMTF — home
Stock

MARKSANS

Marksans Pharma Limited
Health Technology

Daily Margin Trading Facility book for MARKSANS across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹144 Cr
as of 10 Sep 2026
Rank in book
#264
407 days tracked
Share of book
0.09%
of the whole NSE + BSE book
Peak funded
₹145 Cr
on 09 Sep 2026
Largest single-day addition
+₹15 Cr
on 15 Oct 2025
Largest single-day unwind
−₹12 Cr
on 21 Aug 2026

NSE & BSE split

How MARKSANS’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹139 Cr · 96.4%BSE ₹5 Cr · 3.6%

MTF vs Price

Margin-funded outstanding for MARKSANS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹329.40
as of 11 Sep 2026
Price, 30 days
+27.5%
adjusted for splits and bonuses
Delivery, 20-day avg
34.6%
of traded volume actually settled
Sessions to unwind
6.0
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day−₹0−0.1%−0.1%
−4,649
+0.1%unwinding into strength
10 days+₹19+15.1%+8.3%
+4,12,448
+1.3%building into strength
30 days+₹32+28.4%+6.6%
+3,31,881
+27.8%building into strength
90 days+₹45+44.7%+14.2%
+6,68,627
+30.9%building into strength
180 days+₹69+92.5%+41.0%
+15,62,413
+96.2%building into strength
1 year+₹81+128.5%+79.4%
+23,79,065
+79.3%building into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where MARKSANS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

MARKSANS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026144−₹00.09%264
09 Sep 2026145+₹40.09%264
08 Sep 2026141+₹70.09%273
07 Sep 2026134+₹30.09%291
04 Sep 2026131+₹00.09%295
03 Sep 2026130+₹00.09%293
02 Sep 2026130+₹70.09%296
01 Sep 2026123−₹10.08%310
31 Aug 2026124+₹20.08%309
28 Aug 2026122−₹30.08%313
27 Aug 2026126−₹10.08%304
26 Aug 2026126−₹00.08%300
25 Aug 2026126+₹40.08%300
24 Aug 2026123+₹00.08%311
21 Aug 2026122−₹120.08%311
20 Aug 2026135−₹10.09%278
19 Aug 2026136−₹10.09%275
18 Aug 2026137+₹40.09%269
17 Aug 2026133+₹100.09%277
14 Aug 2026123−₹00.08%302
13 Aug 2026123+₹30.08%300
12 Aug 2026120+₹70.08%306
11 Aug 2026113−₹00.08%323
10 Aug 2026114−₹00.08%316
07 Aug 2026114−₹00.08%309
06 Aug 2026115+₹00.08%312
05 Aug 2026114+₹10.08%311
04 Aug 2026114−₹10.08%313
03 Aug 2026114+₹10.08%304
31 Jul 2026113—0.08%309

MARKSANS within Health Technology

Ranked #11 of 61 funded Health Technology stocks, carrying 2.3% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
9DRREDDY
Dr. Reddy's Laboratories Limited
₹1702.7%
10LUPIN
Lupin Limited
₹1702.7%
11MARKSANS
Marksans Pharma Limited
₹1442.3%
12MOREPENLAB
Morepen Laboratories Limited
₹1422.2%
13BLUEJET
Blue Jet Healthcare Limited
₹1412.2%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.